The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-24), ClearPoint Neuro's share price is $5.32. ClearPoint Neuro's Book Value per Share for the quarter that ended in Dec. 2023 was $0.86. Hence, ClearPoint Neuro's PB Ratio of today is 6.19.
The historical rank and industry rank for ClearPoint Neuro's PB Ratio or its related term are showing as below:
CLPT'
s PB Ratio Range Over the Past 10 Years
Min: 2.29 Med: 7.76 Max: 1536.67
Current: 6.19
During the past 13 years, ClearPoint Neuro's highest PB Ratio was 1536.67. The lowest was 2.29. And the median was 7.76.
CLPT's PB Ratio is ranked worse than 85.43% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 2.21
vs CLPT: 6.19
During the past 12 months, ClearPoint Neuro's average Book Value Per Share Growth Rate was -42.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 83.50% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 61.10% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of ClearPoint Neuro was 146.90% per year. The lowest was -36.60% per year. And the median was 70.80% per year.
Back to Basics: PB Ratio
ClearPoint Neuro PB Ratio Historical Data
The historical data trend for ClearPoint Neuro's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ClearPoint Neuro's PB Ratio
For the Medical Devices subindustry, ClearPoint Neuro's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ClearPoint Neuro's PB Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ClearPoint Neuro's PB Ratio distribution charts can be found below:
* The bar in red indicates where ClearPoint Neuro's PB Ratio falls into.
ClearPoint Neuro PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
ClearPoint Neuro's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
ClearPoint Neuro PB Ratio Related Terms
Thank you for viewing the detailed overview of ClearPoint Neuro's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
ClearPoint Neuro (ClearPoint Neuro) Business Description
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use in the United States, is used to perform minimally invasive surgical procedures in the brain and ClearTrace is used to perform minimally invasive surgical procedures in the heart. The company's products and product candidates include ClearPoint neuro system, MRI-guided drug delivery, and Thermal therapy system.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CLPT has been successfully added to your 